Neurite Outgrowth Mediated by Translation Elongation Factor eEF1A1: A Target for Antiplatelet Agent Cilostazol

Cilostazol, a type-3 phosphodiesterase (PDE3) inhibitor, has become widely used as an antiplatelet drug worldwide. A recent second Cilostazol Stroke Prevention Study demonstrated that cilostazol is superior to aspirin for prevention of stroke after an ischemic stroke. However, its precise mechanisms...

Descripción completa

Detalles Bibliográficos
Autores principales: Hashimoto, Kenji, Ishima, Tamaki
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046984/
https://www.ncbi.nlm.nih.gov/pubmed/21390260
http://dx.doi.org/10.1371/journal.pone.0017431

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046984/
https://www.ncbi.nlm.nih.gov/pubmed/21390260
http://dx.doi.org/10.1371/journal.pone.0017431

Ejemplares similares